The shareholders in iCoat Medical AB (publ), org. nr 559172-8208 (the “Company“), are hereby convened to the extraordinary general meeting on Wednesday, December 15, 2021 at 10.00 AM at the Company’s premises at WeWork, floor 6, Malmskillnadsgatan 32, 111 51 Stockholm.
Shareholders who wish to participate at the extraordinary general meeting must:
- on Tuesday, December 7, 2021 be registered in his or her own name (not nominee registered) in the share register kept by Euroclear Sweden AB, and
- notify his or her intention to attend the general meeting received by the Company no later than Friday, December 10 2021, by mail to address iCoat Medical, c/o Peder Waern, Norrbackagatan 70 A, 113 34 Stockholm stating ” extraordinary general meeting” or by email to firstname.lastname@example.org. Such notification shall include the shareholder’s name, personal identification number or company registration number (or similar), address and daytime telephone number, number of shares, details on advisors, if any, and where applicable, details of representatives or proxies..
To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must register for the meeting and temporarily re-register their shares in their own names in the share register maintained by Euroclear Sweden AB in order to be entitled to attend the general meeting. Such registration must be duly effected in the share register on December 7, 2021, and the shareholders must therefore advise their nominees well in advance of such date. Registration of voting rights that have been requested by shareholders at such a time that the registration has been made by the relevant nominee no later than Thursday, December 9, 2021 will be taken into account in the production of the share register.
Shareholders represented by proxy must submit a dated and signed proxy. If the proxy is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The proxy may not be valid for a period longer than five years from its issuance. The original proxy and certificate of registration should be submitted to the Company by post at the address mentioned above in due time prior to the general meeting. The Company provides a form of proxy at request and it is also available at the Company’s website, www.icoatmedical.se.
- Opening of the general meeting
- Election of chairman of the general meeting
- Preparation and approval of the voting list
- Approval of the agenda
- Election of one or two persons to verify the minutes
- Determination as to whether the meeting has been duly convened
- Election of board member
- Election of nomination committee
- Resolution on an issue of new warrants with deviation from the shareholders’ pre-emption rights (1)
- Resolution on an issue of new warrants with deviation from the shareholders’ pre-emption rights (2)
- Resolution on authorization for the board of directors to issue new warrants
- Closing of the general meeting
- Fullmaktsformulär – iCoat Medical AB
- Kallelse EBS 15 dec, iCoat Medical AB
- Notice EGM 15 dec, iCoat Medical AB
- Proxy form, iCoat Medical AB
- Styrelsens förslag – bemyndigande avseende teckningsoptioner – iCoat Medical AB
- Styrelsens förslag – emission av teckningsoptioner – iCoat Medical
- Valberedningens förslag – emission av teckningsoptioner. iCoat Medical AB
- Villkor för teckningsoptioner 2021_2023_1 (Styrelsens förslag) – iCoat Medical AB
- Villkor för teckningsoptioner 2021_2023_2 (Valberedningens förslag) – iCoat Medical AB